Amra Uzicanin, MD, MPH
Unit Lead, Community Interventions for Infection Control Unit (CI-ICU),
Division of Global Migration and Quarantine
Dr. Uzicanin has been the lead of DGMQ’s Community Interventions for Infection Control Unit (CI-ICU) since it was established in 2010. CI-ICU is dedicated to developing the scientific evidence base and policies for the use of nonpharmaceutical interventions (NPIs) for infectious disease control in community settings with a focus on pandemic influenza. Her prior experience in infectious disease control and epidemiology has provided a great foundation for her work with the Unit.
Before coming to CDC‚ Dr. Uzicanin was a practicing physician‚ and served for five years with the International Federation of Red Cross and Red Crescent Societies (IFRC) as medical coordinator in multiple countries affected by armed conflicts. There‚ she directed efforts to provide health care for refugees‚ internally displaced persons‚ and other vulnerable populations. Prior to joining DGMQ‚ she served with CDC’s Global Immunization Division first as an EIS officer 1998–2000‚ and then until 2010 as a medical epidemiologist supporting global immunization activities‚ conducting epidemiologic research related to global and regional measles and rubella control targets‚ and supporting global polio eradication. This work included close collaboration with the World Health Organization‚ UNICEF‚ and national public health authorities in multiple countries. During the 2009 Influenza A (H1N1) pandemic response‚ Dr. Uzicanin was detailed to CDC’s Vaccine Task Force where she helped design and complete a U.S. school-based evaluation of pandemic vaccine effectiveness.
Dr. Uzicanin obtained her medical degree from the University in Sarajevo‚ Bosnia and Herzegovina‚ and received her MPH degree from the Emory University in Atlanta. She resides in Atlanta with her husband‚ and they both enjoy visiting state parks throughout Georgia as well as many of Atlanta’s art venues.
- Page last reviewed: October 5, 2017
- Page last updated: October 5, 2017
- Content source: